Consistent with its CD47-inducing property, butyrate treatment significantly prevented CRC cells from being phagocytosed by macrophages, whereas this effect was counteracted by CD47 blocking antibody (Fig. 3G). This evidence concerns the gene CD47 and colorectal carcinoma.